---
category: news
title: "iCAD's ProFound AI for Digital Breast Tomosynthesis Version 3.0 Receives CE Mark Approval"
excerpt: "NASHUA, N.H., (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ:ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions,"
publishedDateTime: 2021-06-14T12:00:00Z
originalUrl: "https://www.benzinga.com/pressreleases/21/06/g21546658/icads-profound-ai-for-digital-breast-tomosynthesis-version-3-0-receives-ce-mark-approval"
webUrl: "https://www.benzinga.com/pressreleases/21/06/g21546658/icads-profound-ai-for-digital-breast-tomosynthesis-version-3-0-receives-ce-mark-approval"
ampWebUrl: "https://www.benzinga.com/amp/content/21546658"
cdnAmpWebUrl: "https://www-benzinga-com.cdn.ampproject.org/c/s/www.benzinga.com/amp/content/21546658"
type: article
quality: 30
heat: 30
published: false

provider:
  name: Benzinga.com
  domain: benzinga.com

topics:
  - AI in Healthcare
  - AI

secured: "pKX+DVcGkOZXHi8CK78zCDgCcDUW74qIGG1xM0SIJ00lJ6+bSXyeppWWujgvBKiamDg/hVPNzMGaPCzixzCegVA4gUGQ8pLKV/PIgbj/lkT9SI5pHSSEWG+RQ9EWnrVkwzJU1VPonQJxa1fOGcQfg2k8zPvz/HqsXpwnuNxiCGEA9NlbTzn59FSGe5Je0TJmcJ7uVGofaEnLiZyd8JaCNofIcTZq73gTOxnUxP1aWML1s2dIQ9hFWvdcQy5j6e2s7+gJzi1in/2B/Yuk3GVe+2m66IoRW4ZOZ2c1QAB6jT/1PnCO8nQS03ScMm60QsodkYRgathVElaPgIdzc0SGFVf0yl2CYWjALIYaIl7govw=;Ooub5gYCxtgVLVmEi1awOw=="
---

